Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Feb;9(1):156-157.
doi: 10.21037/tlcr.2019.12.11.

Cavity development: a potential biomarker for antiangiogenesis agents

Man Jiang  1 , Xiaochun Zhang  1
Affiliations
Comment

Cavity development: a potential biomarker for antiangiogenesis agents

Man Jiang et al. Transl Lung Cancer Res. 2020 Feb.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: The authors have no conflicts of interest to declare.

Comment on

References

    1. Calvetti L, Aprile G. Influence and mechanism of lung cavitation development on antiangiogenic therapy: is cavitation the new caveat? Transl Lung Cancer Res 2019;8:319-22. 10.21037/tlcr.2019.08.19 - DOI - PMC - PubMed
    1. Cecere FL, Aguilar A, Rosell R. Lung cavitation in lung metastases of gastric and non-small-cell lung cancer patients treated with apatinib. Transl Lung Cancer Res 2019;8:317-8. 10.21037/tlcr.2019.08.20 - DOI - PMC - PubMed
    1. Huang C, Wang X, Wang J, et al. Incidence and clinical implication of tumor cavitation in patients with advanced non-small cell lung cancer induced by Endostar, an angiogenesis inhibitor. Thorac Cancer 2014;5:438-46. 10.1111/1759-7714.12115 - DOI - PMC - PubMed
    1. Marom EM, Martinez CH, Truong MT, et al. Tumor cavitation during therapy with antiangiogenesis agents in patients with lung cancer. J Thorac Oncol 2008;3:351-7. 10.1097/JTO.0b013e318168c7e9 - DOI - PubMed
    1. Nishino M, Cryer SK, Okajima Y, et al. Tumoral cavitation in patients with non-small-cell lung cancer treated with antiangiogenic therapy using bevacizumab. Cancer Imaging 2012;12:225-35. 10.1102/1470-7330.2012.0027 - DOI - PMC - PubMed